Who owns DRUGS MADE IN AMERICA ACQUISITN UNT?
- Ticker: DMAAU
- CUSIP Number: g2847j120
Tip: Access positions for across all investors
Analyze quarterly positions in Drugs Made In America Acquisitn Unt with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Drugs Made In America Acquisitn Unt stock
Who bought or sold DRUGS MADE IN AMERICA ACQUISITN UNT this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Omni Event Management | 300k | $3.0M | 100% | Sep 2025 |
|
| Wolverine Asset Management | 130k | $1.4M | 0% | Sep 2025 |
|
| Rivernorth Capital Management | 102k | $1.1M | -76% | Sep 2025 |
|
| DLD Asset Management | 100k | $22k | 0% | Sep 2025 |
|
| Clear Street | 46k | $474k | 685% | Jun 2025 |
|
| Robinson Capital Management | 30k | $314k | 0% | Sep 2025 |
|
| Tuttle Tactical Management | 20k | $208k | 0% | Sep 2025 |
|
| UBS Group | 18k | $191k | 0% | Sep 2025 |
|
| Citadel Advisors | 12k | $125k | -15% | Sep 2025 |
|
Who sold out of Drugs Made In America Acquisitn Unt?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Context Capital Management | Jun 2025 | 250k | $2.6M |
| Brooklyn Capital Management | Jun 2025 | 57k | $591k |